Page last updated: 2024-11-12

neuropeptide y (13-36)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID134813886
MeSH IDM0173925

Synonyms (6)

Synonym
gtpl1535
human neuropeptide y (13-36)
npy-(13-36) (human)
npy-(13-36)
neuropeptide y (13-36)
gtpl3903

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Moreover, the specific pattern of cardiorespiratory responses elicited by NPY(13-36) was remarkably similar, over approximately the same dosage range, with the cardiorespiratory response pattern elicited by intact NPY."( Y2 receptors for neuropeptide Y in the nucleus of the solitary tract mediate depressor responses.
Anderson, GF; Barraco, RA; Dunbar, JC; Ergene, E; Ganduri, YL,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1346365Rat Y2 receptor (Neuropeptide Y receptors)2001Molecular pharmacology, Jul, Volume: 60, Issue:1
The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (70)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's46 (65.71)18.2507
2000's17 (24.29)29.6817
2010's6 (8.57)24.3611
2020's1 (1.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other76 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]